PMID- 7564103 OWN - NLM STAT- MEDLINE DCOM- 19951114 LR - 20190725 IS - 0085-2538 (Print) IS - 0085-2538 (Linking) VI - 48 IP - 2 DP - 1995 Aug TI - Human mesangial cell production of monocyte chemoattractant protein-1: modulation by lovastatin. PG - 363-71 AB - Macrophages play a critical role in the progression of clinical and experimental glomerular injury. Serum-stimulated human fetal mesangial cells in culture produce a chemotactic factor that is monocyte-selective. This chemotactic factor is most likely monocyte chemoattractant protein-1 (MCP-1) as a monoclonal antibody directed against MCP-1, but not an irrelevant antibody, suppressed the mesangial cell-derived chemotactic activity. Inhibition of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase by lovastatin resulted in a reduction of the mesangial cell-derived chemotactic activity as well as MCP-1 mRNA expression. The inhibitory effects of lovastatin in the presence of exogenous cholesterol were reversed by mevalonate, suggesting a role for isoprenoid intermediates of the mevalonate pathway and/or isoprenylated proteins in mesangial cell MCP-1 regulation. These findings suggest an additional mechanism by which HMG-CoA reductase inhibition in vivo may reduce glomerular injury. FAU - Kim, S Y AU - Kim SY AD - Department of Medicine, Hennepin County Medical Center, Minneapolis, Minnesota, USA. FAU - Guijarro, C AU - Guijarro C FAU - O'Donnell, M P AU - O'Donnell MP FAU - Kasiske, B L AU - Kasiske BL FAU - Kim, Y AU - Kim Y FAU - Keane, W F AU - Keane WF LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - Kidney Int JT - Kidney international JID - 0323470 RN - 0 (Chemokine CCL2) RN - 0 (Hydroxymethylglutaryl-CoA Reductase Inhibitors) RN - 0 (RNA, Messenger) RN - 9LHU78OQFD (Lovastatin) SB - IM MH - Cells, Cultured MH - Chemokine CCL2/*biosynthesis/genetics MH - Glomerular Mesangium/cytology/*metabolism MH - Humans MH - Hydroxymethylglutaryl-CoA Reductase Inhibitors MH - Lovastatin/*pharmacology MH - RNA, Messenger/antagonists & inhibitors/metabolism MH - Time Factors EDAT- 1995/08/01 00:00 MHDA- 1995/08/01 00:01 CRDT- 1995/08/01 00:00 PHST- 1995/08/01 00:00 [pubmed] PHST- 1995/08/01 00:01 [medline] PHST- 1995/08/01 00:00 [entrez] AID - S0085-2538(15)59076-5 [pii] AID - 10.1038/ki.1995.304 [doi] PST - ppublish SO - Kidney Int. 1995 Aug;48(2):363-71. doi: 10.1038/ki.1995.304.